Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hutchison China MediTech Ltd.

www.chi-med.com

Latest From Hutchison China MediTech Ltd.

Finance Watch: BioNTech, Vir Launch IPOs But Take US Offerings To Market At A Discount

BioNTech's $150m offering, after a prior large venture capital financing, gives it the third-largest market cap for a newly public drug developer in the US. Also, Innovent raises $300m in Hong Kong offering, Heron leads US follow-ons and Five Prime restructures to save $20m annually.
Financing StartUps and SMEs

Eight Talking Points From ESMO

Proving once again that it is a match for ASCO, here are highlights from the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona from 27 September to 1 October.

Clinical Trials Research & Development

Trend Revising? Biotech IPOs Slow Sharply In HK While Shanghai's STAR Shines

Just one year ago, biotechs were queuing up to list in Hong Kong following a relaxation of rules, but now many are postponing plans or simply shifting away, impacted by the market's low valuations, fast-changing environment and surprisingly strong competition from a new Shanghai trading section.  

Financing China

Boost For Chi-Med As Phase III NET Study Stopped Early On PFS Benefit

Chi-Med is setting a course straight for the Chinese FDA after its targeted therapy hit its PFS target ahead of schedule in neuroendocrine tumors.

Clinical Trials Cancer
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Alias(es)
  • Chi-Med
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Hong Kong
  • Parent & Subsidiaries
  • Hutchison China MediTech Ltd.
  • Senior Management
  • Christian Hogg, CEO
    Johnny Cheng, CFO
    Weiguo Su, MD, EVP, CSO
  • Contact Info
  • Hutchison China MediTech Ltd.
    Phone: (852) 2128 1188
    22nd Fl., Hutchison House
    10 Harcourt Rd.
    ,
    Hong Kong
Advertisement
Advertisement
UsernamePublicRestriction

Register